CUSIP 90400D108COMRAREQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
282 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 10.26M | $236.07M | +131.1K | Added |
| 2 | Blackrock, Inc. | 6.63M | $152.53M | +206.3K | Added |
| 3 | State Street Corp | 4.30M | $98.97M | +610.6K | Added |
| 4 | Jpmorgan Chase & Co | 3.97M | $91.40M |
| Reduced |
| 5 | Sands Capital Management, LLC | 3.49M | $80.17M | −284.1K | Reduced |
| 6 | Rtw Investments, LP | 3.00M | $69.00M | −258.1K | Reduced |
| 7 | Baker Bros. Advisors LP | 2.77M | $63.77M | 0 | Held |
| 8 | Fmr LLC | 2.67M | $61.32M | −4.62M | Reduced |
| 9 | Wellington Management Group LLP | 2.46M | $56.62M | +516.8K | Added |
| 10 | Citadel Advisors LLC | 2.33M | $53.50M | +2.00M | Added |
See every fund holding Ultragenyx Pharmaceutical In, with full quarter-over-quarter share changes.
Unlock all holders